Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.

Saved in:
Bibliographic Details
Title: Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.
Authors: Searle AK; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia., Chen YC; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia., Wallert M; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., McFadyen JD; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.; Clinical Haematology, Alfred Hospital, Melbourne, Australia., Maluenda AC; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., Noonan J; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia., Kanellakis P; Atherosclerosis and Cell Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., Zaldivia MTK; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., Huang A; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., Lioe H; CSL Limited, Bio21 Institute, Parkville, Melbourne, Australia., Biondo M; CSL Limited, Bio21 Institute, Parkville, Melbourne, Australia., Nolte MW; CSL Behring Innovation GmbH, Marburg, Germany., Rossato P; CSL Behring Innovation GmbH, Marburg, Germany., Bobik A; Department of Medicine, Monash University, Melbourne, Australia.; Atherosclerosis and Cell Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Immunology, Monash University, Melbourne, Australia., Panousis C; CSL Limited, Bio21 Institute, Parkville, Melbourne, Australia., Wang X; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia., Hosseini H; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia., Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.; Department of Immunology, Monash University, Melbourne, Australia.; Department of Cardiology, Alfred Hospital, Melbourne, Australia.
Source: Thrombosis and haemostasis [Thromb Haemost] 2022 Feb; Vol. 122 (2), pp. 196-207. Date of Electronic Publication: 2022 Jan 21.
Publication Type: Journal Article
Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-689X (Electronic) Linking ISSN: 03406245 NLM ISO Abbreviation: Thromb Haemost Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2567-689X
DOI:10.1055/a-1663-8208